D60057|white
DEXYANE MeD PALPEBRAL treats atopic and contact eczema lesions and limits their recurrence. Its "ultra-hydrating dressing effect" immediately soothes, decongests and protects the skin.
Medical Device
DEXYANE MED
Palpebral
Skin
Atopic or contact eyelid eczema
/
Eczema
DEXYANE MeD PALPEBRAL treats atopic and contact eczema lesions and limits their recurrence. Its "ultra-hydrating dressing effect" immediately soothes, decongests and protects the skin.
DEXYANE MED Palpebral treats and limits the recurrence of eyelid eczema lesions. Ultra-hydrating dressing-effect texture:
Dexyane MeD Palpebral can be used as stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids. Its efficacy has been clinically proven.
Results:
Available in 15 ml tube.
(1) Result of a clinical study conducted on 33 adults from 19-70 years old with mild to moderate atopic or contact eyelid eczema. Dexyane MeD was applied twice a day to the eyelids for 22 days. The clinical severity score (including itching, burning, tightness, etc.) from 0 to 9, immediately after 3 days of application, was compared to the pre-application scores. Immediately, the itching score significantly decreased, and the burning score improved by day 3. (2) The overall development of lesions was evaluated by the PGA score on a 5-point scale: 0 (aggravation) to 4 (completely healed); after 3 days of application, the majority of patients felt an improvement. PFDC study PRM03-F-197_V3_AN. 03/2019. 98-104, 108.
DEXYANE MED Palpebral treats and limits the recurrence of eyelid eczema lesions. Ultra-hydrating dressing-effect texture:
- instantly relieves and decongests
- soothes itching and pain, reduces redness and irritations.
- restores the skin barrier
- limits bacterial adhesion
Dexyane MeD Palpebral can be used as stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids. Its efficacy has been clinically proven.
Results:
- Immediately reduces itching (1)
- At day 3, significant improvement and even complete disappearance of clinical signs, particularly burning sensations.(1)
Available in 15 ml tube.
(1) Result of a clinical study conducted on 33 adults from 19-70 years old with mild to moderate atopic or contact eyelid eczema. Dexyane MeD was applied twice a day to the eyelids for 22 days. The clinical severity score (including itching, burning, tightness, etc.) from 0 to 9, immediately after 3 days of application, was compared to the pre-application scores. Immediately, the itching score significantly decreased, and the burning score improved by day 3. (2) The overall development of lesions was evaluated by the PGA score on a 5-point scale: 0 (aggravation) to 4 (completely healed); after 3 days of application, the majority of patients felt an improvement. PFDC study PRM03-F-197_V3_AN. 03/2019. 98-104, 108.
- 51% Hydra-nourishing phase (glycerin, shea butter and triglycerides)
- Natural polysaccharide mesh
- Hydroxydecine
- Enoxolone
Fragrance-free, cortisone-free, nickel-tested
Detailed formula (INCI) :
WATER (AQUA). GLYCERIN. CAPRYLIC/CAPRIC TRIGLYCERIDE. BUTYLENE GLYCOL. POLYSORBATE 60. BUTYROSPERMUM PARKII (SHEA) BUTTER (BUTYROSPERMUM PARKII BUTTER). PROPYLENE GLYCOL. BEESWAX (CERA ALBA). GLYCERYL STEARATE. PEG-100 STEARATE. 10-HYDROXYDECENOIC ACID. CAPRYLYL GLYCOL. CETYL ALCOHOL. DISODIUM EDTA. GLYCYRRHETINIC ACID. POLYACRYLATE-13. POLYISOBUTENE. POLYSORBATE 20. SCLEROTIUM GUM. SORBITAN ISOSTEARATE. CITRIC ACID.
The ingredients list is subject to modifications, we recommend you check the list on the purchased product.
- Eczema is a common skin disease that can affect babies, children and adults. It is characterized by the formation of skin lesions (redness, vesicles and scabs) marked by flare-ups and intense skin dryness. Pain and itching is sometimes intense and can disrupt the daily lives of eczema patients.
- Eyelid eczema: This area is frequently affected by eczema because the skin on the eyelids is very fine and therefore easier for irritants and allergens to penetrate. It predominantly affects women. The main cause is allergic reactions, caused via direct contact (application of cosmetics, eyedrops, etc.), via hands (nail polish, etc.), or via airways (sprays, fragrances, etc.). It can also be caused by irritants (irritating, harsh products, etc.), and atopy.
- Eyelid eczema damages self-esteem and is even worse for women, since it impedes make-up application.
Dexyane MeD Palpebral is a medical device, a regulated health product which carries, in accordance with this regulation, the CE 0459 mark. Read the instructions in the leaflet carefully. Not to be used by pregnant or breastfeeding women. Avoid all direct contact with eyes. Ages 3 months and up. Manufacturer: Pierre Fabre Medical Devices. Updated: August 2019. 230769.
Benefits
DEXYANE MeD PALPEBRAL treats atopic and contact eczema lesions and limits their recurrence. Its "ultra-hydrating dressing effect" immediately soothes, decongests and protects the skin.
DEXYANE MED Palpebral treats and limits the recurrence of eyelid eczema lesions. Ultra-hydrating dressing-effect texture:
Dexyane MeD Palpebral can be used as stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids. Its efficacy has been clinically proven.
Results:
Available in 15 ml tube.
(1) Result of a clinical study conducted on 33 adults from 19-70 years old with mild to moderate atopic or contact eyelid eczema. Dexyane MeD was applied twice a day to the eyelids for 22 days. The clinical severity score (including itching, burning, tightness, etc.) from 0 to 9, immediately after 3 days of application, was compared to the pre-application scores. Immediately, the itching score significantly decreased, and the burning score improved by day 3. (2) The overall development of lesions was evaluated by the PGA score on a 5-point scale: 0 (aggravation) to 4 (completely healed); after 3 days of application, the majority of patients felt an improvement. PFDC study PRM03-F-197_V3_AN. 03/2019. 98-104, 108.
Dexyane MeD Palpebral is a medical device, a regulated health product which carries, in accordance with this regulation, the CE 0459 mark. Read the instructions in the leaflet carefully. Not to be used by pregnant or breastfeeding women. Avoid all direct contact with eyes. Ages 3 months and up. Manufacturer: Pierre Fabre Medical Devices. Updated: August 2019. 230769.
DEXYANE MED Palpebral treats and limits the recurrence of eyelid eczema lesions. Ultra-hydrating dressing-effect texture:
- instantly relieves and decongests
- soothes itching and pain, reduces redness and irritations.
- restores the skin barrier
- limits bacterial adhesion
Dexyane MeD Palpebral can be used as stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids. Its efficacy has been clinically proven.
Results:
- Immediately reduces itching (1)
- At day 3, significant improvement and even complete disappearance of clinical signs, particularly burning sensations.(1)
Available in 15 ml tube.
(1) Result of a clinical study conducted on 33 adults from 19-70 years old with mild to moderate atopic or contact eyelid eczema. Dexyane MeD was applied twice a day to the eyelids for 22 days. The clinical severity score (including itching, burning, tightness, etc.) from 0 to 9, immediately after 3 days of application, was compared to the pre-application scores. Immediately, the itching score significantly decreased, and the burning score improved by day 3. (2) The overall development of lesions was evaluated by the PGA score on a 5-point scale: 0 (aggravation) to 4 (completely healed); after 3 days of application, the majority of patients felt an improvement. PFDC study PRM03-F-197_V3_AN. 03/2019. 98-104, 108.
Dexyane MeD Palpebral is a medical device, a regulated health product which carries, in accordance with this regulation, the CE 0459 mark. Read the instructions in the leaflet carefully. Not to be used by pregnant or breastfeeding women. Avoid all direct contact with eyes. Ages 3 months and up. Manufacturer: Pierre Fabre Medical Devices. Updated: August 2019. 230769.
Composition
- 51% Hydra-nourishing phase (glycerin, shea butter and triglycerides)
- Natural polysaccharide mesh
- Hydroxydecine
- Enoxolone
Fragrance-free, cortisone-free, nickel-tested
Detailed formula (INCI) :
WATER (AQUA). GLYCERIN. CAPRYLIC/CAPRIC TRIGLYCERIDE. BUTYLENE GLYCOL. POLYSORBATE 60. BUTYROSPERMUM PARKII (SHEA) BUTTER (BUTYROSPERMUM PARKII BUTTER). PROPYLENE GLYCOL. BEESWAX (CERA ALBA). GLYCERYL STEARATE. PEG-100 STEARATE. 10-HYDROXYDECENOIC ACID. CAPRYLYL GLYCOL. CETYL ALCOHOL. DISODIUM EDTA. GLYCYRRHETINIC ACID. POLYACRYLATE-13. POLYISOBUTENE. POLYSORBATE 20. SCLEROTIUM GUM. SORBITAN ISOSTEARATE. CITRIC ACID.
The ingredients list is subject to modifications, we recommend you check the list on the purchased product.
A word from the dermatologist
- Eczema is a common skin disease that can affect babies, children and adults. It is characterized by the formation of skin lesions (redness, vesicles and scabs) marked by flare-ups and intense skin dryness. Pain and itching is sometimes intense and can disrupt the daily lives of eczema patients.
- Eyelid eczema: This area is frequently affected by eczema because the skin on the eyelids is very fine and therefore easier for irritants and allergens to penetrate. It predominantly affects women. The main cause is allergic reactions, caused via direct contact (application of cosmetics, eyedrops, etc.), via hands (nail polish, etc.), or via airways (sprays, fragrances, etc.). It can also be caused by irritants (irritating, harsh products, etc.), and atopy.
- Eyelid eczema damages self-esteem and is even worse for women, since it impedes make-up application.
Applicable tips
-
Apply a thin layer directly to inflammatory eyelid eczema lesions with a clean finger, avoiding any contact with the eye. For external use only. Can be used as stand-alone treatment, in combination with, and/or as a follow-up to topical corticosteroids. Once or twice a day. Babies from 3 months and up, children, adults.
-
Do not use if you are allergic to one of the ingredients. In case of an allergic reaction, consult a doctor. In the absence of available data, do not use if pregnant or breastfeeding. Keep out of the reach of children. Avoid all direct contact with eyes. Close the tube tightly after use. Do not use the product if the tube is damaged. In case of adverse effects related to product use, consult a doctor.
-
Can be used on skin weakened by cancer treatments.
Applicable tips
-
Apply a thin layer directly to inflammatory eyelid eczema lesions with a clean finger, avoiding any contact with the eye. For external use only. Can be used as stand-alone treatment, in combination with, and/or as a follow-up to topical corticosteroids. Once or twice a day. Babies from 3 months and up, children, adults.
-
Do not use if you are allergic to one of the ingredients. In case of an allergic reaction, consult a doctor. In the absence of available data, do not use if pregnant or breastfeeding. Keep out of the reach of children. Avoid all direct contact with eyes. Close the tube tightly after use. Do not use the product if the tube is damaged. In case of adverse effects related to product use, consult a doctor.
-
Can be used on skin weakened by cancer treatments.